Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer.

When we compared mutations in the other exons (1, 4, 7, and 13) with the clinicopathological parameters, we found a trend toward enrichment of the mutations in lower grade tumors, but this trend did not reach statistical significance ( p = 0.104).

also in 111,027 other papers